References
Almaaytah A, Abualhaijaa A, & Alqudah O (2019). The evaluation of the
synergistic antimicrobial and antibiofilm activity of AamAP1-Lysine with
conventional antibiotics against representative resistant strains of
both Gram-positive and Gram-negative bacteria. Infect Drug Resist
12: 1371-1380.
Almaaytah A, Farajallah A, Abualhaijaa A, & Al-Balas Q (2018). A3, a
Scorpion Venom Derived Peptide Analogue with Potent Antimicrobial and
Potential Antibiofilm Activity against Clinical Isolates of Multi-Drug
Resistant Gram Positive Bacteria. Molecules 23.
Almaaytah A, Tarazi S, Abu-Alhaijaa A, Altall Y, Alshar’i N, Bodoor
K, et al. (2014). Enhanced Antimicrobial Activity of
AamAP1-Lysine, a Novel Synthetic Peptide Analog Derived from the
Scorpion Venom Peptide AamAP1. Pharmaceuticals (Basel) 7:502-516.
Almaaytah A, Zhou M, Wang L, Chen T, Walker B, & Shaw C (2012).
Antimicrobial/cytolytic peptides from the venom of the North African
scorpion, Androctonus amoreuxi: biochemical and functional
characterization of natural peptides and a single site-substituted
analog. Peptides 35: 291-299.
Ardal C, Balasegaram M, Laxminarayan R, McAdams D, Outterson K, Rex
JH, et al. (2020). Antibiotic development - economic, regulatory
and societal challenges. Nat Rev Microbiol 18: 267-274.
Bell G, & MacLean C (2018). The Search for ’Evolution-Proof’
Antibiotics. Trends Microbiol 26: 471-483.
Bjorn C, Noppa L, Naslund Salomonsson E, Johansson AL, Nilsson E,
Mahlapuu M, et al. (2015). Efficacy and safety profile of the
novel antimicrobial peptide PXL150 in a mouse model of infected burn
wounds. Int J Antimicrob Agents 45: 519-524.
Brogden KA (2005). Antimicrobial peptides: pore formers or metabolic
inhibitors in bacteria? Nat Rev Microbiol 3: 238-250.
Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, & White TC (2012).
Hidden killers: human fungal infections. Sci Transl Med 4:165rv113.
Brown GD, Denning DW, & Levitz SM (2012). Tackling human fungal
infections. Science 336: 647.
Cao J, Wu P, Cheng Q, He C, Chen Y, & Zhou J (2021). Ultrafast
Fabrication of Self-Healing and Injectable Carboxymethyl Chitosan
Hydrogel Dressing for Wound Healing. ACS applied materials & interfaces
13: 24095-24105.
Cebrian R, Xu C, Xia Y, Wu W, & Kuipers OP (2021). The
cathelicidin-derived close-to-nature peptide D-11 sensitises Klebsiella
pneumoniae to a range of antibiotics in vitro, ex vivo and in vivo. Int
J Antimicrob Agents 58: 106434.
Curren EJ, Lutgring JD, Kabbani S, Diekema DJ, Gitterman S, Lautenbach
E, et al. (2022). Advancing Diagnostic Stewardship for
Healthcare-Associated Infections, Antibiotic Resistance, and Sepsis.
Clin Infect Dis 74: 723-728.
Echaiz JF, Burnham CA, & Bailey TC (2013). A case of Apophysomyces
trapeziformis necrotizing soft tissue infection. Int J Infect Dis
17: e1240-1242.
Fisher MC, Henk DA, Briggs CJ, Brownstein JS, Madoff LC, McCraw
SL, et al. (2012). Emerging fungal threats to animal, plant and
ecosystem health. Nature 484: 186-194.
Gao W, & Zhang L (2021). Nanomaterials arising amid antibiotic
resistance. Nat Rev Microbiol 19: 5-6.
Ghosh C, Sarkar P, Issa R, & Haldar J (2019). Alternatives to
Conventional Antibiotics in the Era of Antimicrobial Resistance. Trends
Microbiol 27: 323-338.
Hancock REW, Alford MA, & Haney EF (2021). Antibiofilm activity of host
defence peptides: complexity provides opportunities. Nat Rev Microbiol
19: 786-797.
Hofer U (2019). The cost of antimicrobial resistance. Nat Rev Microbiol
17: 3.
Hofer U (2022). Rise in global antibiotic use. Nat Rev Microbiol
20: 63.
Larsson DGJ, & Flach CF (2021). Antibiotic resistance in the
environment. Nat Rev Microbiol.
Lei R, Hou J, Chen Q, Yuan W, Cheng B, Sun Y, et al. (2018).
Self-Assembling Myristoylated Human alpha-Defensin 5 as a
Next-Generation Nanobiotics Potentiates Therapeutic Efficacy in
Bacterial Infection. Acs Nano 12: 5284-5296.
Liang YP, He JH, & Guo BL (2021). Functional Hydrogels as Wound
Dressing to Enhance Wound Healing. Acs Nano 15: 12687-12722.
Liang YQ, Li ZL, Huang Y, Yu R, & Guo BL (2021). Dual-Dynamic-Bond
Cross-Linked Antibacterial Adhesive Hydrogel Sealants with On-Demand
Removability for Post-Wound-Closure and Infected Wound Healing. Acs Nano
15: 7078-7093.
Makabenta JMV, Nabawy A, Li CH, Schmidt-Malan S, Patel R, & Rotello VM
(2021). Nanomaterial-based therapeutics for antibiotic-resistant
bacterial infections. Nat Rev Microbiol 19: 23-36.
Mwangi J, Yin Y, Wang G, Yang M, Li Y, Zhang Z, et al. (2019).
The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas
aeruginosa and Acinetobacter baumannii infection. Proceedings of the
National Academy of Sciences of the United States of America.
Nibbering PH, Goblyos A, Adriaans AE, Cordfunke RA, Ravensbergen B,
Rietveld MH, et al. (2019). Eradication of meticillin-resistant
Staphylococcus aureus from human skin by the novel LL-37-derived peptide
P10 in four pharmaceutical ointments. Int J Antimicrob Agents
54: 610-618.
Pambos OJ, & Kapanidis AN (2019). Tracking antibiotic mechanisms. Nat
Rev Microbiol 17: 201.
Pfaller MA, & Diekema DJ (2007). Epidemiology of invasive candidiasis:
a persistent public health problem. Clin Microbiol Rev 20:133-163.
Song M, Liu Y, Huang X, Ding S, Wang Y, Shen J, et al. (2020). A
broad-spectrum antibiotic adjuvant reverses multidrug-resistant
Gram-negative pathogens. Nat Microbiol 5: 1040-1050.
van der Weide H, Vermeulen-de Jongh DMC, van der Meijden A, Boers SA,
Kreft D, Ten Kate MT, et al. (2019). Antimicrobial activity of
two novel antimicrobial peptides AA139 and SET-M33 against clinically
and genotypically diverse Klebsiella pneumoniae isolates with differing
antibiotic resistance profiles. Int J Antimicrob Agents 54:159-166.